A large catalogue, a low quotation, or a polished sales presentation does not prove that a pharma supplier can consistently deliver approved, traceable products. You will be able to screen suppliers, verify their permissions, examine quality evidence, test commercial fit, and sign an agreement with clear accountability.
Key takeaways
- Define quality, delivery, cost, and service requirements before requesting quotations.
- Verify the manufacturing site, licence numbers, permissions, and product approvals in official records.
- Request batch records, certificates of analysis, storage evidence, and recall procedures before approval.
- Compare territory demand, delivered cost, minimum orders, and written supplier responsibilities.
Define “top supplier” before you request quotations
A top pharma product supplier repeatedly delivers products made at authorised premises against approved specifications, with complete batch records, traceable materials, controlled storage, and a workable complaint and recall system. Sales claims, catalogue size, low prices, attractive packaging, and promises of exclusive territory rights do not prove product quality.
Begin your pharma supplier evaluation with the legal entity name, registered address, manufacturing site, product list, dosage forms, strengths, and intended supply model. Request:
- The manufacturing licence, product permissions, GST registration, company identification details, and manufacturing-site address.
- Current product specifications, pharmacopoeial references, packaging artwork, and the supplier’s complaint and recall procedure.
- A clear statement of whether each product uses a manufacturing licence, loan licence, or contract manufacturing arrangement.
Create a product-by-product screening table instead of approving the company in the abstract. For every tablet, syrup, supplement, or injection, record the approved manufacturer, licence type, premises, dosage form, strength, pack size, storage condition, and proposed shelf life.
A licence covering tablets does not automatically cover sterile injections, a different strength, or another product category. Confirm that each permission matches the specific premises, dosage form, strength, product category, and sterile operation where applicable.
Reject any supplier that will not identify who manufactures, tests, releases, stores, and handles complaints for each product. Without those names and records, you cannot trace a failed batch, assess a recall, or distinguish an authorised product from a sales promise.
Verify the supplier, site, and permissions with official records
Match every submitted document to an official record before approving the supplier. Check the legal name, GSTIN, registered address, manufacturing premises, licence number, issuing authority, validity period, and named dosage forms with the relevant Indian drug-control department or state drug-control authority.
Use the following verification sequence:
- Search the authority’s licence or manufacturer database for the premises and licence number.
- Confirm the permission covers the product category, dosage form, strength, pack, and sterile operation where applicable.
- Contact the licensing authority when no online record exists or a scanned page is unclear.
- Compare the permission with the proposed label, composition, pack size, and manufacturing site.
- Request the latest inspection report or written inspection outcome, open CAPA list, unresolved observations, and evidence that earlier deficiencies were closed.
A generic manufacturing licence does not authorise every marketed item. Tablet permission does not prove approval for an injection, a different strength, or another site.
| Supplier role | What it means | Contract question |
|---|---|---|
| Manufacturer | Controls production under its own licence | Who releases each batch? |
| Third-party manufacturer | Makes products for another brand owner | Who controls specifications and deviations? |
| Marketer | Owns the commercial presentation without operating a factory | Who handles complaints and recalls? |
| PCD pharma franchise supplier | Provides products and territory rights while relying on an outside manufacturer | Which premises and licence cover each product? |
Name the responsible party in the contract. It must assign manufacturing responsibility, batch release, complaint receipt, complaint investigation, recalls, records, audits, and regulatory communication. A purchase order alone leaves these duties unclear.
Examine the batch evidence, GMP controls, and product risk
A generic Certificate of Analysis proves nothing about the stock delivered. Approve a supplier only after matching documents to a physical batch and checking the controls behind its results.
1. Inspect each Certificate of Analysis for the exact product name, batch number, manufacturing and expiry dates, specification version, test methods, individual results, approval status, authorised signatory, and laboratory identity. Match it to the supplied batch and retain the batch release record; reject a blank template as evidence.
2. Request stability data from the marketed container-closure system: long-term studies at 25°C/60% RH or 30°C/65% RH, accelerated studies at 40°C/75% RH when applicable, and an ongoing stability commitment for successive batches. Accelerated data alone do not establish the full shelf life.
3. Review GMP controls through batch traceability from API and excipients to finished packs, supplier qualification, deviations, out-of-specification investigations, change control, CAPA, sanitation, environmental monitoring, audit trails, and data-integrity controls. Records must be attributable, legible, contemporaneous, original, and accurate. For APIs, identify the API manufacturer and supply chain, not only the finished-dose site.
4. For sterile injections, request media-fill results, environmental-monitoring trends, personnel qualification, container-closure integrity, endotoxin controls, sterilisation validation where relevant, and excursion investigations. Finished-batch sterility testing cannot replace aseptic-process control.
Inspect samples for seal integrity, print accuracy, pack condition, storage instructions, and label conformity. Use independent or witnessed testing for critical results before quality approval.
Test catalogue fit against territory demand and delivered cost
A portfolio is commercially useful only when it matches territory demand, prescriber behaviour, and delivered margin—not when its catalogue is merely large. A practical pharma product catalogue evaluation maps every item to prescription demand, prescriber acceptance, local competition, therapeutic duplication, dosage form, strength, pack size, seasonal demand, and the customer types you already serve.
| Check | What to compare | Commercial warning |
|---|---|---|
| Demand | Prescriptions, seasonality, prescriber preferences | Stock concentrates in one therapy area |
| Product fit | Approved composition, strength, dosage form, pack size | Chemical similarity is mistaken for equivalence |
| Supply economics | MOQ, batch size, shelf life, freight, returns | Low unit price hides expiry or working-capital cost |
For generics, request the bioequivalence, dissolution, clinical, or waiver evidence required in the target market. Confirm that the evidence covers the supplied strength, dosage form, manufacturing site, and packaging.
Calculate delivered cost using:
- Unit price, freight, temperature-controlled transport, testing, and promotional material
- Minimum order quantity, batch size, and remaining shelf life at dispatch
- Breakage, expiry returns, credit terms, and release lead time
- Forecast rules, shortage allocation, shortage notification, and approved-substitute policy
For temperature-sensitive products, request qualified vehicles or packaging, temperature mapping, calibration records, excursion limits, and the rejection decision procedure. Check FSSAI category, ingredient limits, mandatory declarations, and disease-treatment claims separately for supplements.
In a PCD pharma franchise comparison, apply this commercial due diligence to the actual territory and customer mix; when assessing kelps healthcare, use the same tests rather than treating monopoly rights as proof of fit.
Approve the supplier only after responsibilities are written down
Approve a supplier only after a documented score covers legal verification, sample results, the quality dossier, inspection findings, commercial terms, storage capability, and complaint history. Escalate unresolved deviations, open CAPAs, unexplained COA results, missing permissions, or repeated delivery excursions to a quality decision-maker, not sales staff.
| Review area | Approve when | Escalate or reject when |
|---|---|---|
| Legal and quality | Permissions, inspection findings, CAPAs, samples, and COAs match the proposed products | A licence, result, or inspection response remains unexplained |
| Supply continuity | Storage controls, release lead time, shelf life, allocation, and shortage notice are documented | Excursions recur or supply depends on verbal promises |
| Commercial control | Returns, substitutes, recalls, and costs have named owners | The lowest price hides weak continuity or quality controls |
For contract or private-label supply, sign a quality agreement with the commercial agreement. Assign these duties by name:
- Batch release, specifications, sampling, testing, deviations, OOS investigations, and change notification
- Document retention, audit access, complaints, recalls, regulatory communication, and the recall procedure
- Minimum remaining shelf life, release lead time, shortage notice, allocation rules, approved-substitute controls, recall costs, and returns
Write pharmacovigilance duties into the agreement: who receives adverse-event reports, performs medical assessment, conducts signal detection, and escalates urgent safety information. Check artwork and claims against approved product information and Schedule H, H1, and X requirements; approve supplement claims under applicable FSSAI rules.
Reassess through COA checks, trend reviews, audits, complaint analysis, change-control notices, and continued process-verification evidence. Renew approval only when records demonstrate control, not because pricing remains attractive.
Frequently asked questions
What should you define before requesting pharmaceutical supplier quotations?
Set measurable requirements for product specifications, dosage forms, quantities, delivery timelines, storage conditions, payment terms, complaint handling, and territory rights before comparing quotations.
How can you verify a pharmaceutical supplier and manufacturing site?
Check the company identity, manufacturing address, licence numbers, permissions, and product approvals against official government or regulatory records. Confirm that the quotation names the same legal entity and site.
What batch and GMP evidence should you examine?
Request a sample certificate of analysis, batch number format, manufacturing and expiry dates, approved product specifications, traceability records, storage logs, deviation handling, and recall procedures. Match these documents to the product and manufacturing site.
How do you test whether a supplier's catalogue fits your territory?
Compare dosage forms and strengths with local prescribing demand, calculate delivered cost including freight and taxes, check minimum order quantities, assess expiry at delivery, and test the supplier's stock and replenishment capacity.
What should be written down before approving a pharma supplier?
Document product specifications, order quantities, prices, delivery terms, storage responsibilities, returns, complaints, recalls, quality investigations, change notifications, payment terms, and any exclusive territory rights.
